Remove 2023 Remove Complication Remove Diabetes Remove Electronics
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

4 Chronic Kidney Disease The FLOW trial randomized 3,534 patients with chronic kidney disease and type 2 diabetes and started treating them with s.c. The study was terminated early because benefits were already significantly visible by October 2023. semaglutide 1.0 mg or placebo in 2019. mg is not recommended. mg is not recommended.

Diabetes 130
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

Share Tweet Share Email Home Psychology & Psychiatry Home Addiction June 16, 2025 The GIST Texas invests $50M in psychedelic drug research to treat addiction by I. Consider supporting Science Xs mission by getting a premium account.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

But what we observed was much more complicated." The traditional model is simple: SCN neurons were believed to act like runners in a relay race, passing the light signal along in a linear chain. Some SCN neurons were activated by light, while others were inhibited. Consider supporting Science Xs mission by getting a premium account.

Provider 109
article thumbnail

Allowing Patients to Die: Louise Aronson and Bill Andereck

GeriPal

Louise 05:02 Yes, well, I don’t know about 2024, but in 2023, yes, it could happen. Alex 15:13 This is really complicated. He was a terrible diabetic. And in fact, after a complicated ethics issue, we will oftentimes go in and try and debrief them. It happened to my mother. Louise, what happened to your mom?